[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Status and Outlook 2018-2025

July 2018 | 197 pages | ID: GB49C1BD708EN
99Strategy

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Snapshot

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1: Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2: Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3: Product Segment Overview and Market Status
Part 4: Application / End-User Segment Overview and Market Status
Part 5: Region Segment Overview and Market Status
Part 6: Product & Application Segment Production & Demand by Region
Part 7: Market Forecast by Product, Application & Region
Part 8: Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9: Market Competition and Environment for New Entrants
Part 10: Conclusion

Market Segment as follows:

Key Companies
  • Novo Nordisk
  • AstraZeneca
  • Eli Lily
  • GSK
  • Sanofi
  • Bristol-Myers Squibb
  • Amylin
Market by Type
  • Exenatied
  • Liraglutide
  • Lixisenatide
  • Albiglutide
  • Dulaglutide
Market by Application
  • Hospital
  • Pharmacy
  • Others
PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Glucagon Like Peptide-1 (GLP-1) Agonists Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Exenatied
  3.1.2 Liraglutide
  3.1.3 Lixisenatide
  3.1.4 Albiglutide
  3.1.5 Dulaglutide
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Hospital
  4.1.2 Pharmacy
  4.1.3 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sultan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Exenatied Production by Region
    6.1.1.2 Liraglutide Production by Region
    6.1.1.3 Lixisenatide Production by Region
    6.1.1.4 Albiglutide Production by Region
    6.1.1.5 Dulaglutide Production by Region
  6.1.2 Production by Application
    6.1.2.1 Hospital Production by Region
    6.1.2.2 Pharmacy Production by Region
    6.1.2.3 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Exenatied Demand by Region
    6.2.1.2 Liraglutide Demand by Region
    6.2.1.3 Lixisenatide Demand by Region
    6.2.1.4 Albiglutide Demand by Region
    6.2.1.5 Dulaglutide Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Hospital Demand by Region
    6.2.2.2 Pharmacy Demand by Region
    6.2.2.3 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Novo Nordisk
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 AstraZeneca
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Eli Lily
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 GSK
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Sanofi
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Bristol-Myers Squibb
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Amylin
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

LIST OF TABLES

Table Glucagon Like Peptide-1 (GLP-1) Agonists Industry Dynamics & Regulations List
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Revenue, Cost and Margin, 2015-2018E
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Status by Type 2015-2018E, in USD Million
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Status by Application 2015-2018E, in USD Million
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Status by Application 2015-2018E, in Volume
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market by Region 2015-2018E, in USD Million
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Region in 2018, in USD Million
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market by Region 2015-2018E, in Volume
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Region in 2018, in Volume
Table Exenatied Production Value by Region 2015-2018E, in USD Million
Table Exenatied Production Volume by Region 2015-2018E, in Volume
Table Liraglutide Production Value by Region 2015-2018E, in USD Million
Table Liraglutide Production Volume by Region 2015-2018E, in Volume
Table Lixisenatide Production Value by Region 2015-2018E, in USD Million
Table Lixisenatide Production Volume by Region 2015-2018E, in Volume
Table Albiglutide Production Value by Region 2015-2018E, in USD Million
Table Albiglutide Production Volume by Region 2015-2018E, in Volume
Table Dulaglutide Production Value by Region 2015-2018E, in USD Million
Table Dulaglutide Production Volume by Region 2015-2018E, in Volume
Table Hospital Production Value by Region 2015-2018E, in USD Million
Table Hospital Production Volume by Region 2015-2018E, in Volume
Table Pharmacy Production Value by Region 2015-2018E, in USD Million
Table Pharmacy Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Exenatied Market Size by Region 2015-2018E, in USD Million
Table Exenatied Market Size by Region 2015-2018E, in Volume
Table Liraglutide Market Size by Region 2015-2018E, in USD Million
Table Liraglutide Market Size by Region 2015-2018E, in Volume
Table Lixisenatide Market Size by Region 2015-2018E, in USD Million
Table Lixisenatide Market Size by Region 2015-2018E, in Volume
Table Albiglutide Market Size by Region 2015-2018E, in USD Million
Table Albiglutide Market Size by Region 2015-2018E, in Volume
Table Dulaglutide Market Size by Region 2015-2018E, in USD Million
Table Dulaglutide Market Size by Region 2015-2018E, in Volume
Table Hospital Market Size by Region 2015-2018E, in USD Million
Table Hospital Market Size by Region 2015-2018E, in Volume
Table Pharmacy Market Size by Region 2015-2018E, in USD Million
Table Pharmacy Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalGlucagon Like Peptide-1 (GLP-1) Agonists Forecast by Type 2019F-2025F, in USD Million
Table Glucagon Like Peptide-1 (GLP-1) Agonists Forecast by Type 2019F-2025F, in Volume
Table Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast by Region 2019F-2025F, in USD Million
Table Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast by Region 2019F-2025F, in Volume
Table Novo Nordisk Information
Table Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Cost, Margin of Novo Nordisk
Table AstraZeneca Information
Table Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Cost, Margin of AstraZeneca
Table Eli Lily Information
Table Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Cost, Margin of Eli Lily
Table GSK Information
Table Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Cost, Margin of GSK
Table Sanofi Information
Table Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Cost, Margin of Sanofi
Table Bristol-Myers Squibb Information
Table Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Cost, Margin of Bristol-Myers Squibb
Table Amylin Information
Table Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Cost, Margin of Amylin
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Revenue by Company 2015-2017, in USD Million
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume by Company 2015-2017, in Volume
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume by Company in 2018, in Volume

LIST OF FIGURES

Figure Glucagon Like Peptide-1 (GLP-1) Agonists Picture
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Industry Chain Diagram
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Revenue 2015-2018E, in USD Million
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume 2015-2018E, in Volume
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Status by Type 2015-2018E, in Volume
Figure North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2015-2018E, in USD Million
Figure North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2015-2018E, in Volume
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2015-2018E, in USD Million
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2015-2018E, in Volume
Figure South America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2015-2018E, in USD Million
Figure South America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2015-2018E, in Volume
Figure Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2015-2018E, in Volume
Figure Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2015-2018E, in USD Million
Figure Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2015-2018E, in Volume
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price Forecast 2019F-2025F
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Gross Margin Forecast 2019F-2025F
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Revenue by Company in 2018, in USD Million
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Company in 2018
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Gross Margin by Company in 2018

More Publications

Need Help?

Ask a Question

Market Reports

All Categories